Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $7.5 Million - $12.6 Million
-200,032 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $2.53 Million - $11.7 Million
200,032 New
200,032 $9.35 Million
Q4 2019

Feb 14, 2020

SELL
$8.93 - $12.41 $197,183 - $274,025
-22,081 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$8.8 - $14.5 $194,312 - $320,174
22,081 New
22,081 $227,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $450M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.